Single thermal pulsation treatment improves MGD symptoms

SAN DIEGO — A single thermal pulsation treatment improved symptoms in patients with meibomian gland dysfunction, according to a study presented here.At the American Society of Cataract and Refractive Surgery meeting, Alice T. Epitropoulos, MD, FACS, described a retrospective study of 51 patients with meibomian gland dysfunction (MGD) who received a 12-minute single thermal pulsation treatment of LipiFlow (TearScience), either unilaterally or bilaterally, with follow-up at 6 to 8 weeks.